LARAZOTIDE ACETATE
UNII FO8S2IW40N

Substance Identification & Data

This profile provides standardized clinical and technical data for Larazotide Acetate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FO8S2IW40N.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 881851-50-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
FO8S2IW40N
CAS Registry Number
881851-50-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
LARAZOTIDE ACETATE
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
USAN ID
TT-07
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Larazotide Acetate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LARAZOTIDE ACETATE

Common Names & Synonyms

GLYCINE, GLYCYLGLYCYL-L-VALYL-L-LEUCYL-L-VALYL-L-GLUTAMINYL-L-PROLYL-, MONOACETATE
GLYCYLGLYCYL-L-VALYL-L-LEUCYL-L-VALYL-L-GLUTAMINYL-L-PROLYLGLYCINE ACETATE
LARAZOTIDE ACETATE [USAN]
LARAZOTIDE ACETATE [WHO-DD]

Technical Codes

AT-1001
AT-1001 (LARAZOTIDE ACETATE)